Loading...

FDA APPROVES Digital Psych Meds!

advertisement
Nov 15 | By Kemet1luv

WASHINGTON (AP) — The Food and Drug Administration has approved the first drug in the United States with a digital ingestion tracking system in an unprecedented step to ensure that patients with mental disorders take the medicine prescribed for them.


The drug Abilify MyCite was developed by Otsuka Pharmaceutical Co., Ltd. Abilify was first approved by the FDA in 2002 to treat schizophrenia, and the ingestible sensor, made by Proteus Digital health, was initially approved for marketing in 2012. The agency says the digitally enhanced medication "works by sending a message from the pill's sensor to a wearable patch."

Dr. Mitchell Mathis of the FDA says officials support "use of new technology in prescription drugs and is committed to working with companies to understand how the new technology might benefit patients and prescribers."


READ MORE CLICK HERE


Comments:

No comments
You need to sign in to comment

Related Articles

advertisement
Enter your twitter handle.
Enter your Google Plus profile or page ID (e.g., 103708169695782281000).
Enter your Facebook page username.

Advertisement

advertisement
Black Conscious Dating Community! Kemetklique.com is an exclusive niche dating community for culturally and socially conscious black people. Conscious black singles are online now in our active community. Kemetklique.com is designed for dating, sharing conscious thought, building strong relationships, and friendships. Join Kemetklique.com today and meet other conscious black singles and your compatible match. Kemetklique.com brings black love and online dating together! Ankh Udja Seneb. Ase.
Password protected photo
Password protected photo
Password protected photo